Skip to main content
. Author manuscript; available in PMC: 2020 Jan 21.
Published in final edited form as: Chem Soc Rev. 2019 Jan 21;48(2):415–427. doi: 10.1039/c7cs00748e

Figure 11.

Figure 11.

Schematic representation for fabrication of vancomycin encapsulated gelatin nanoparticles with RBC membrane coating layer (Van⊂SGNPs@RBC). (b) Diagram showing the ability of Van⊂SGNPs@RBC to evade macrophage recognition and release drugs in presence of bacterial infection. Graph shows drug releasing profiles of NPs in presence of gelatinase (+/−) bacteria. Reproduced from reference 49 with permission from American Chemical Society, Copyright © 2014.